Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/60865
Title: Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells
Author: Veigel, Daniel
Wagner, Renate
Stübiger, Gerald
Wuczkowski, Michael
Filipits, Martin
Horvat, Reinhard
Benhamú, Bellinda
López-Rodríguez, María Luz
Leisser, Asha
Valent, Peter
Grusch, Michael
Hegardt, Fausto
García Gómez, Jordi
Serra i Cucurull, Dolors
Auersperg, Nelly
Colomer, Ramón
Grunt, Thomas
Keywords: Trompes de Fal·lopi
Cèl·lules epitelials
Càncer d'ovari
Vellesa
Àcids grassos
Fallopian tubes
Epithelial cells
Ovarian cancer
Old age
Fatty acids
Issue Date: 3-Nov-2014
Publisher: Wiley
Abstract: Ovarian cancer (OC) is caused by genetic aberrations in networks that control growth and survival. Importantly, aberrant cancer metabolism interacts with oncogenic signaling providing additional drug targets. Tumors overexpress the lipogenic enzyme fatty acid synthase (FASN) and are inhibited by FASN blockers, whereas normal cells are FASN-negative and FASN-inhibitor-resistant. Here, we demonstrate that this holds true when ovarian/oviductal cells reside in their autochthonous tissues, whereas in culture they express FASN and are FASN-inhibitor-sensitive. Upon subculture, nonmalignant cells cease growth, express senescence-associated β-galactosidase, lose FASN and become FASN-inhibitor-resistant. Immortalized ovarian/oviductal epithelial cell lines although resisting senescence reveal distinct growth activities, which correlate with FASN levels and FASN drug sensitivities. Accordingly, ectopic FASN stimulates growth in these cells. Moreover, FASN levels and lipogenic activities affect cellular lipid composition as demonstrated by thin-layer chromatography. Correlation between proliferation and FASN levels was finally evaluated in cancer cells such as HOC-7, which contain subclones with variable differentiation/senescence and corresponding FASN expression/FASN drug sensitivity. Interestingly, senescent phenotypes can be induced in parental HOC-7 by differentiating agents. In OC cells, FASN drugs induce cell cycle blockade in S and/or G2/M and stimulate apoptosis, whereas in normal cells they only cause cell cycle deceleration without apoptosis. Thus, normal cells, although growth-inhibited, may survive and recover from FASN blockade, whereas malignant cells get extinguished. FASN expression and FASN drug sensitivity are directly linked to cell growth and correlate with transformation/differentiation/senescence only indirectly. FASN is therefore a metabolic marker of cell proliferation rather than a marker of malignancy and is a useful target for future drug development.
Note: Versió postprint del document publicat a: http://dx.doi.org/10.1002/ijc.29261
It is part of: International Journal of Cancer, vol. 136 num. 9, 2015, p. 2078-2090
Related resource: http://dx.doi.org/10.1002/ijc.29261
URI: http://hdl.handle.net/2445/60865
ISSN: 0020-7136
Appears in Collections:Articles publicats en revistes (Química Inorgànica i Orgànica)

Files in This Item:
File Description SizeFormat 
645394.pdf1.55 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.